Pfizer Quarterly Corporate Performance — Fourth Quarter 2009

Audio Webcast  — Conference
call for Analysts and Investors
Wednesday, February 3, 2010
10:00 AM E.D.T.

Read press release issued December 23, 2009 (PDF)

More Investor Presentations

2009 Corporate Responsibility Report

Part of being a responsible company is operating with transparency. That's why
Pfizer has created a Corporate Responsibility Report to detail our priorities: discovering and developing new medicines, improving access to medicines and partnering to find health system solutions.

View the Interactive 2009 Corporate Responsibility Report

Wyeth Transaction
Important Information for Investors

Access key merger documents 

Effective October 15, 2009 Pfizer Inc. acquired Wyeth in a cash and stock merger. Pursuant to the terms of the merger, Wyeth holders will receive 0.985 of a share of Pfizer Inc. common stock and $33.00, without interest for every 1 share of Wyeth common stock they own as of the effective date. Holders who own their shares in "street name" or with a broker are urged to contact their broker accordingly for further instructions. Registered holders who hold either certificates, book entry shares and/or participate in the Wyeth BuyDIRECT Stock Purchase and Sale Plan dividend reinvest program will receive information in the mail shortly regarding how to exchange their shares.

Access key merger documents 

Working Mother 100 Best Companies

Pfizer has been named among the 2009 Working Mother 100 Best Companies.

View the press release
Visit workingmother.com

Best Places to Work for LGBT Equality

View the press release